GPX4 and cancer: We also conducted a sensitivity analysis of organoids to NRF2 inhibitor CP and GPX4 inhibitor RSL3 and found that metastasis cancer cells were more sensitive to ferroptosis inducers compared to primary tumor cancer cells (s-Fig. 2D), which consistent with our hypothesis.